Programmbereich Infektionen

Klinische Infektiologie

Mission    Projekte    Drittmittel    Methoden    Publikationen    Mitarbeiter/innen

Publikationen

2021

Chesov D, Butov D, Reimann M, Heyckendorf J, Myasoedov V, Butov T, Akymenko O, Lange C. Impact of lung function on treatment outcome in patients with TB. Int J Tuberc Lung Dis. 2021 Apr 1;25(4):277-284. doi: 10.5588/ijtld.20.0949. PMID: 33762071.

Guglielmetti L, Kontsevaya I, Leoni MC, Ferrante P, Fronti E, Gerna L, Valdatta C, Donisi A, Faggi A, Paolillo F, Ratti G, Ruggieri A, Scotti M, Sacchini D, Taliani G, Codeluppi M; COVID-Piacenza Group. Severe COVID-19 pneumonia in Piacenza, Italy - A cohort study of the first pandemic wave. J Infect Public Health. 2021 Feb;14(2):263-270. doi: 10.1016/j.jiph.2020.11.012. Epub 2020 Dec 9. PMID: 33497876; PMCID: PMC7723761.

Grobbel HP, Merker M, Köhler N, Andres S, Hoffmann H, Heyckendorf J, Reimann M, Barilar I, Dreyer V, Hillemann D, Kalsdorf B, Kohl TA, Sanchez-Carballo P, Schaub D, Todt K, Utpatel C, Maurer FP, Lange C, Niemann S. Design of multidrug-
resistant tuberculosis treatment regimens based on DNA sequencing. Clin Infect Dis. 2021 Apr 26:ciab359. doi: 10.1093/cid/ciab359. Epub ahead of print. PMID: 33900387.

Heyckendorf J, Marwitz S, Reimann M, Avsar K, DiNardo A, Günther G, Hoelscher M, Ibraim E, Kalsdorf B, Kaufmann SHE, Kontsevaya I, van Leth F, Mandalakas AM, Maurer FP, Müller M, Nitschkowski D, Olaru ID, Popa C, Rachow A, Rolling T,
Rybniker J, Salzer HJF, Sanchez-Carballo P, Schuhmann M, Schaub D, Spinu V, Suárez I, Terhalle E, Unnewehr M, Weiner J 3rd, Goldmann T, Lange C. Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model.
Eur Respir J. 2021 Feb 11:2003492. doi: 10.1183/13993003.03492-2020. Epub ahead of print. PMID: 33574078.

Lange C, Chesov D, Konstatynovska O, Mandalakas AM, Udwadia Z. Sorry for the delay. Clin Microbiol Infect. 2021 Apr 3:S1198-743X(21)00142-7. doi: 10.1016/j.cmi.2021.03.007. Epub ahead of print. PMID: 33823271.
Mandalakas AM, Hesseling AC, Kay A, Du Preez K, Martinez L, Ronge L, DiNardo A, Lange C, Kirchner HL. Tuberculosis prevention in children: a prospective community-based study in South Africa. Eur Respir J. 2021 Apr 22;57(4):2003028. doi: 10.1183/13993003.03028-2020. PMID: 33122339; PMCID: PMC8060782.

Molina-Moya B, Guglielmetti L, Bothamley G, van Leth F, Lange C, Dominguez J. Use and impact of molecular methods for detecting drug-resistant TB. Int J Tuberc Lung Dis. 2021 Feb 1;25(2):157-159. doi: 10.5588/ijtld.20.0527. PMID:
33656431.

Pfeuffer-Jovic E, Heyckendorf J, Reischl U, Bohle RM, Bley T, Buck A, Wilkens H, Schäfers HJ, Langen HJ, Held M. Pulmonary vasculitis due to infection with Mycobacterium goodii: A case report. Int J Infect Dis. 2021 Mar;104:178-180. doi: 10.1016/j.ijid.2020.12.074. Epub 2020 Dec 29. PMID: 33383220.

Sachsenweger J, Scheu KM, Lange C, Terhalle E. 35/w mit zervikaler Lymphadenopathie : Vorbereitung auf die Facharztprüfung: Fall 32 [35/f-Cervical lymphadenopathy : Preparation for the medical specialist examination: part 32].
Internist (Berl). 2021 Apr 16. German. doi: 10.1007/s00108-021-00998-y. Epub ahead of print. PMID: 33860807.

Sachsenweger J, Scheu KM, Lange C, Terhalle E. 24/w mit chronischem Husten : Vorbereitung auf die Facharztprüfung: Fall 45 [24/f-Chronic cough : Preparation for the medical specialist examination: part 45]. Internist (Berl). 2021 Mar 22.
German. doi: 10.1007/s00108-021-01005-0. Epub ahead of print. PMID: 33751138.

Stellmacher F, Kirfel J, Kalsdorf B, Maurer FP, Perner S, Goldmann T. Molekularpathologie der Tuberkulose : Stellenwert, Methodik und Grenzen [Molecular pathology of tuberculosis : Status, methodology, and limits]. Pathologe. 2021 Feb;42(1):78-82. German. doi: 10.1007/s00292-021-00911-2. Epub 2021 Jan 21. PMID: 33475809.

Feuerriegel, S, Kohl, TA, Utpatel, C, Andres, S, Maurer, FP, Heyckendorf, J, Jouet, A, Badalato, N, Foray, L, Kamara, RF, Conteh, OS, Supply, P & Niemann, S 2021, 'Rapid genomic first- and second-line drug resistance prediction from clinical Mycobacterium tuberculosis specimens using Deeplex®-MycTB', The European respiratory journal, Jg. 57, Nr. 1. https://doi.org/10.1183/13993003.01796-2020

Benet, S, Gálvez, C, Drobniewski, F, Kontsevaya, I, Arias, L, Monguió-Tortajada, M, Erkizia, I, Urrea, V, Ong, R-Y, Luquin, M, Dupont, M, Chojnacki, J, Dalmau, J, Cardona, P, Neyrolles, O, Lugo-Villarino, G, Vérollet, C, Julián, E, Furrer, H, Günthard, HF, Crocker, PR, Tapia, G, Borràs, FE, Fellay, J, McLaren, PJ, Telenti, A, Cardona, P-J, Clotet, B, Vilaplana, C, Martinez-Picado, J & Izquierdo-Useros, N 2021, 'Dissemination of Mycobacterium tuberculosis is associated to a SIGLEC1 null variant that limits antigen exchange via trafficking extracellular vesicles', Journal of extracellular vesicles, Jg. 10, Nr. 3, S. e12046. https://doi.org/10.1002/jev2.12046

Goldmann, T, Hillemann, D, Maurer, F, Kalsdorf, B, Krupar, R, Stellmacher, F & Perner, S 2021, 'Mycobacterium szulgai als Posititivkontrolle zur Detektion von Kontaminationen beim Nachweis des Mycobacterium tuberculosis-Komplexes durch eine spezifische 16S-rDNA-PCR an FFPE-Material', Der Pathologe, Jg. 42, Nr. 1, S. 83-85. https://doi.org/10.1007/s00292-021-00912-1

Goldmann T, Hillemann D, Maurer F, Kalsdorf B, Krupar R, Stellmacher F, Perner S. Mycobacterium szulgai als Posititivkontrolle zur Detektion von Kontaminationen beim Nachweis des Mycobacterium tuberculosis-Komplexes durch eine spezifische 16S-rDNA-PCR an FFPE-Material [Mycobacterium szulgai as positive control helps to detect contaminations in the detection of Mycobacterium tuberculosis-complex in formalin fixed, paraffin embedded tissues by 16SrDNA PCR]. Pathologe. 2021 Feb;42(1):83-85. German. doi: 10.1007/s00292-021-00912-1. Epub 2021 Jan 21. PMID: 33475807.

 

2020

Bernardes JP, Mishra N, Tran F, Bahmer T, Best L, Blase JI, Bordoni D, Franzenburg J, Geisen U, Josephs-Spaulding J, Köhler P, Künstner A, Rosati E, Aschenbrenner AC, Bacher P, Baran N, Boysen T, Brandt B, Bruse N, Dörr J, Dräger A, Elke G, Ellinghaus D, Fischer J, Forster M, Franke A, Franzenburg S, Frey N, Friedrichs A, Fuß J, Glück A, Hamm J, Hinrichsen F, Hoeppner MP, Imm S, Junker R, Kaiser S, Kan YH, Knoll R, Lange C, Laue G, Lier C, Lindner M, Marinos G, Markewitz R,  Nattermann J, Noth R, Pickkers P, Rabe KF, Renz A, Röcken C, Rupp J, Schaffarzyk A, Scheffold A, Schulte-Schrepping J, Schunk D, Skowasch D, Ulas T, Wandinger KP, Wittig M, Zimmermann J, Busch H, Hoyer BF, Kaleta C, Heyckendorf J, Kox M, Rybniker J, Schreiber S, Schultze JL, Rosenstiel P; HCA Lung Biological Network; Deutsche COVID-19 Omics Initiative (DeCOI). Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19. Immunity. 2020 Dec 15;53(6):1296-1314.e9. doi: 10.1016/j.immuni.2020.11.017. Epub 2020 Nov PMID: 33296687; PMCID: PMC7689306

Chesov D, Heyckendorf J, Alexandru S, Donica A, Chesov E, Reiman M, Crudu V, Botnaru V, Lange C. Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country. Eur Respir J. 2020 Dec 17:2002544. doi: 10.1183/13993003.02544-2020. Epub ahead of print. PMID: 33334942.

Heyckendorf J, Gillespie SH, Ruhwald M. Culture-free proof of Mycobacterium tuberculosis - a new assay for viable bacteria. EBioMedicine. 2020 Dec;62:103117. doi: 10.1016/j.ebiom.2020.103117. Epub 2020 Nov 10. PMID: 33181467; PMCID: PMC7658474.

Nikolayevskyy V, Balabanova Y, Kontsevaya I, Ignatyeva O, Skenders G, Vasiliauskiene E, Bockel DV, Drobniewski F. Biomarkers of treatment success in fully sensitive pulmonary tuberculosis patients: a multicenter longitudinal study. Biomark Med. 2020 Oct;14(15):1439-1452. doi: 10.2217/bmm-2020-0246. Epub 2020 Nov 3. PMID: 33140661.

Abidi, S, Achar, J, Neino, MMA, Bang, D, Benedetti, A, Brode, S, Campbell, JR, Casas, E, Conradie, F, Dravniece, G, du Cros, P, Falzon, D, Jaramillo, E, Kuaban, C, Lan, Z, Lange, C, Li, PZ, Makhmudova, M, Maug, AKJ, Menzies, D, Migliori, GB, Miller, A, Myrzaliev, B, Ndjeka, N, Noeske, J, Parpieva, N, Piubello, A, Schwoebel, V, Sikhondze, W, Singla, R, Souleymane, MB, Trébucq, A, Van Deun, A, Viney, K, Weyer, K, Zhang, BJ & Khan, FA 2020, 'Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis.', The European respiratory journal, Jg. 55, Nr. 3, 1901467. https://doi.org/10.1183/13993003.01467-2019

Andres, S, Merker, M, Heyckendorf, J, Kalsdorf, B, Rumetshofer, R, Indra, A, Hofmann-Thiel, S, Hoffmann, H, Lange, C, Niemann, S & Maurer, FP 2020, 'Bedaquiline-resistant Tuberculosis:Dark Clouds on the Horizon', American journal of respiratory and critical care medicine, Jg. 201, Nr. 12, S. 1564-1568. https://doi.org/10.1164/rccm.201909-1819LE

Bisson GP, Bastos M, Campbell JR, Bang D, Brust JC, Isaakadis P, Lange C, Menzies D, Migliori GB, Pape JW, Palmero D, Baghei P, Tabarsi P, Viiklepp P, Vilbrun S, Walsh J, Marks SM. Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis. Lancet. 2020 Aug 8;396(10248):402-411. doi: 10.1016/S0140-6736(20)31316-7. PMID: 32771107.

Butov, D, Lange, C, Heyckendorf, J, Kalmykova, I, Butova, T, Borovok, N, Novokhatskaya, M & Chesov, D 2020, 'Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine', INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, Jg. 24, Nr. 5, S. 485-491. https://doi.org/10.5588/ijtld.19.0508

Cresswell F, Lange C, van Crevel R. Improving the diagnosis of tuberculous meningitis: good, but not good enough. Clin Microbiol Infect. 2020 Feb;26(2):134-136. doi: 10.1016/j.cmi.2019.10.009. Epub 2019 Oct 19. PubMed PMID: 31639473.

Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment 2017 2020, 'Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis', Lancet Respiratory Medicine, Jg. 8, Nr. 4, S. 383-394. https://doi.org/10.1016/S2213-2600(20)30047-3

Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr, Andrejak C, Böttger EC, Brozek J, Griffith DE, Guglielmetti L, Huitt GA, Knight SL, Leitman P, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, van Ingen J, Wagner D, Winthrop KL. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 2020 Jul 7;56(1):2000535. doi: 10.1183/13993003.00535-2020. PMID: 32636299.

Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ, Andrejak C, Böttger EC, Brozek J, Griffith DE, Guglielmetti L, Huitt GA, Knight SL, Leitman P, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, van Ingen J, Wagner D, Winthrop KL. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline: Executive Summary. Clin Infect Dis. 2020 Jul 6:ciaa241. doi: 10.1093/cid/ciaa241. Epub ahead of print. PMID: 32628747.

Daley, CL, Iaccarino, JM, Lange, C, Cambau, E, Wallace, RJ, Andrejak, C, Böttger, EC, Brozek, J, Griffith, DE, Guglielmetti, L, Huitt, GA, Knight, SL, Leitman, P, Marras, TK, Olivier, KN, Santin, M, Stout, JE, Tortoli, E, van Ingen, J, Wagner, D & Winthrop, KL 2020, 'Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline', CLINICAL INFECTIOUS DISEASES , Jg. 71, Nr. 4, S. 905-913. https://doi.org/10.1093/cid/ciaa1125

Eggeling, J, Heyckendorf, J, Lange, C, Maier, C, Reimann, M, Sassmann-Schweda, A, Shaikh, R, Herzmann, C & Luethgen, M 2020, 'Changes in taste and smell as an early marker for COVID-19', INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , Jg. 99, S. 8-9. https://doi.org/10.1016/j.ijid.2020.07.018

Feuerriegel, S, Kohl, TA, Utpatel, C, Andres, S, Maurer, FP, Heyckendorf, J, Jouet, A, Badalato, N, Foray, L, Kamara, RF, Conteh, OS, Supply, P & Niemann, S 2020, 'Rapid genomic first- and second-line drug resistance prediction from clinical Mycobacterium tuberculosis specimens using Deeplex®-MycTB', The European respiratory journal. https://doi.org/10.1183/13993003.01796-2020

Gupta, RK, Calderwood, CJ, Yavlinsky, A, Krutikov, M, Quartagno, M, Aichelburg, MC, Altet, N, Diel, R, Dobler, CC, Dominguez, J, Doyle, JS, Erkens, C, Geis, S, Haldar, P, Hauri, AM, Hermansen, T, Johnston, JC, Lange, C, Lange, B, van Leth, F, Muñoz, L, Roder, C, Romanowski, K, Roth, D, Sester, M, Sloot, R, Sotgiu, G, Woltmann, G, Yoshiyama, T, Zellweger, J-P, Zenner, D, Aldridge, RW, Copas, A, Rangaka, MX, Lipman, M, Noursadeghi, M & Abubakar, I 2020, 'Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings', NATURE MEDICINE , Jg. 26, Nr. 12, S. 1941-1949. https://doi.org/10.1038/s41591-020-1076-0

Homolka, S, Paulowski, L, Andres, S, Hillemann, D, Jou, R, Günther, G, Claassens, M, Kuhns, M, Niemann, S & Maurer, FP 2020, 'Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding', EMERGING INFECTIOUS DISEASES, Jg. 26, Nr. 11. https://doi.org/10.3201/eid2611.202602

Izquierdo-Garcia, JL, Comella-Del-Barrio, P, Campos-Olivas, R, Villar-Hernández, R, Prat-Aymerich, C, De Souza-Galvão, ML, Jiménez-Fuentes, MA, Ruiz-Manzano, J, Stojanovic, Z, González, A, Serra-Vidal, M, García-García, E, Muriel-Moreno, B, Millet, JP, Molina-Pinargote, I, Casas, X, Santiago, J, Sabriá, F, Martos, C, Herzmann, C, Ruiz-Cabello, J & Domínguez, J 2020, 'Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker', Scientific Reports, Jg. 10, Nr. 1, S. 22317. https://doi.org/10.1038/s41598-020-78999-4

Joean, O, Thiele, T, Schütz, K, Schwerk, N, Sedlacek, L, Kalsdorf, B, Baumann, U & Stoll, M 2020, 'Multidrug-resistant Mycobacterium tuberculosis:a report of cosmopolitan microbial migration and an analysis of best management practices', BMC INFECTIOUS DISEASES , Jg. 20, Nr. 1, S. 678. https://doi.org/10.1186/s12879-020-05381-0

Jünger, C, Reimann, M, Krabbe, L, Gaede, KI, Lange, C, Herzmann, C & Rüller, S 2020, 'Non-invasive ventilation with pursed lips breathing mode for patients with COPD and hypercapnic respiratory failure: A retrospective analysis', PLOS ONE, Jg. 15, Nr. 9, S. e0238619. https://doi.org/10.1371/journal.pone.0238619

Kontsevaya I, Werngren J, Holicka Y, Klaos K, Tran A, Nikolayevskyy V. Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic review. Eur J Clin Microbiol Infect Dis. 2020 Mar;39(3):415-426. doi: 10.1007/s10096-019-03723-8. Epub 2019 Oct 30. PMID: 31667670.

Kwak, N, Winters, N, Campbell, JR, Chan, ED, Gegia, M, Lange, C, Lee, M, Milanov, V, Menzies, D & Yim, J-J 2020, 'Changes in treatment for multidrug-resistant tuberculosis according to national income', The European respiratory journal, Jg. 56, Nr. 5. https://doi.org/10.1183/13993003.01394-2020

Lange C, Dheda K, Chesov D, Mandalakas AM, Udwadia Z, Horsburgh CR Jr. Challenging the management of drug-resistant tuberculosis - Authors' reply. Lancet. 2020 Mar 7;395(10226):783-784. doi: 10.1016/S0140-6736(20)30055-6. PubMed PMID: 32145791.

Lange, C, Aarnoutse, R, Chesov, D, van Crevel, R, Gillespie, SH, Grobbel, H-P, Kalsdorf, B, Kontsevaya, I, van Laarhoven, A, Nishiguchi, T, Mandalakas, A, Merker, M, Niemann, S, Köhler, N, Heyckendorf, J, Reimann, M, Ruhwald, M, Sanchez-Carballo, P, Schwudke, D, Waldow, F & DiNardo, AR 2020, 'Perspective for Precision Medicine for Tuberculosis', FRONTIERS IN IMMUNOLOGY, Jg. 11, S. 566608. https://doi.org/10.3389/fimmu.2020.566608

Lan Z, Ahmad N, Baghaei P, Barkane L, Benedetti A, Brode SK, Brust JCM, Campbell JR, Chang VWL, Falzon D, Guglielmetti L, Isaakidis P, Kempker RR, Kipiani M, Kuksa L, Lange C, Laniado-Laborín R, Nahid P, Rodrigues D, Singla R, Udwadia ZF, Menzies D; Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment 2017. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet Respir Med. 2020 Apr;8(4):383-394. doi: 10.1016/S2213-2600(20)30047-3. Epub 2020 Mar 17. PubMed PMID: 32192585.

Luethgen M, Eggeling J, Heyckendorf J, Lange C, Maier C, Reimann M, Sassmann-Schweda A, Shaikh R, Herzmann C. Changes in taste and smell as an early marker for COVID-19. Int J Infect Dis. 2020 Jul 21:S1201-9712(20)30562-2. doi: 10.1016/j.ijid.2020.07.018. Epub ahead of print. PMID: 32707088; PMCID: PMC7373057.

Martinez L, Cords O, Horsburgh CR, Andrews JR; Pediatric TB Contact Studies Consortium. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. Lancet. 2020 Mar 21;395(10228):973-984. doi: 10.1016/S0140-6736(20)30166-5. PubMed PMID: 32199484.

Naik, SK, Pattanaik, K, Eich, J, Sparr, V, Hauptmann, M, Kalsdorf, B, Reiling, N, Liedtke, W, Kuebler, WM, Schaible, UE & Sonawane, A 2020, 'Differential Roles of the Calcium Ion Channel TRPV4 in Host Responses to Mycobacterium tuberculosis Early and Late in Infection', iScience, Jg. 23, Nr. 6, S. 101206. https://doi.org/10.1016/j.isci.2020.101206

Nikolayevskyy, V, Balabanova, Y, Kontsevaya, I, Ignatyeva, O, Skenders, G, Vasiliauskiene, E, Bockel, DV & Drobniewski, F 2020, 'Biomarkers of treatment success in fully sensitive pulmonary tuberculosis patients: a multicenter longitudinal study', Biomarkers in medicine, Jg. 14, Nr. 15, S. 1439-1452. https://doi.org/10.2217/bmm-2020-0246

NTM-NET 2020, 'Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation', RESPIRATORY MEDICINE , Jg. 173, S. 106164. https://doi.org/10.1016/j.rmed.2020.106164

Otto-Knapp, R, Knappik, M, Häcker, B, Starzacher, K, Bauer, T, Lange, C, Maurer, FP, Schaberg, T & Günther, G 2020, 'Die neuen WHO-Empfehlungen für schnelle Diagnostik und Therapie resistenter Tuberkulose in Deutschland, Österreich und der Schweiz', Pneumologie (Stuttgart, Germany), Jg. 74, Nr. 11, S. 742-749. https://doi.org/10.1055/a-1266-5207

Pediatric TB Contact Studies Consortium & Lange, C 2020, 'The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis', Lancet, Jg. 395, Nr. 10228, S. 973-984. https://doi.org/10.1016/S0140-6736(20)30166-5

Suárez, I, Gruell, H, Heyckendorf, J, Fünger, S, Lichtenstein, T, Jung, N, Lehmann, C, Unnewehr, M, Fätkenheuer, G, Lange, C & Rybniker, J 2020, 'Intensified adjunctive corticosteroid therapy for CNS tuberculomas', Infection. https://doi.org/10.1007/s15010-019-01378-3

Udwadia, ZF, Vora, A, Tripathi, AR, Malu, KN, Lange, C & Sara Raju, R 2020, 'COVID-19 -Tuberculosis interactions: When dark forces collide', The Indian journal of tuberculosis, Jg. 67, Nr. 4S, S. S155-S162. https://doi.org/10.1016/j.ijtb.2020.07.003

Wagner, D & Lange, C 2020, 'Lungenerkrankung durch nicht-tuberkulöse Mykobakterien – Die neue ATS/ERS/ESCMID/IDSA-Leitlinie', Deutsche medizinische Wochenschrift (1946), Jg. 145, Nr. 16, S. 1145-1151. https://doi.org/10.1055/s-0043-124159

Wollenberg, K, Harris, M, Gabrielian, A, Ciobanu, N, Chesov, D, Long, A, Taaffe, J, Hurt, D, Rosenthal, A, Tartakovsky, M & Crudu, V 2020, 'A retrospective genomic analysis of drug-resistant strains of M. tuberculosis in a high-burden setting, with an emphasis on comparative diagnostics and reactivation and reinfection status', BMC INFECTIOUS DISEASES , Jg. 20, Nr. 1, S. 17. https://doi.org/10.1186/s12879-019-4739-z

 

2019

Bittner, S, Engel, S, Lange, C, Weber, MS, Haghikia, A, Luessi, F, Korn, T, Klotz, L, Bayas, A, Paul, F, Heesen, C, Stangel, M, Wildemann, B, Bergh, FT, Tackenberg, B, Trebst, C, Warnke, C, Linker, R, Kerschensteiner, M, Zettl, U, Tumani, H, Brück, W, Meuth, SG, Kümpfel, T, Hemmer, B, Wiendl, H, Gold, R & Zipp, F 2019, 'Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose: Aktueller Stand und Empfehlungen in Deutschland', Der Nervenarzt, Jg. 90, Nr. 12, S. 1245-1253. https://doi.org/10.1007/s00115-019-0760-0

ESGITM Working Group on Vaccination in Migrants & Lange, C 2019, 'National approaches to the vaccination of recently arrived migrants in Europe: A comparative policy analysis across 32 European countriedes', Travel medicine and infectious disease, Jg. 27, S. 33-38. https://doi.org/10.1016/j.tmaid.2018.10.011

Kontsevaya, I, Werngren, J, Holicka, Y, Klaos, K, Tran, A & Nikolayevskyy, V 2019, 'Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic review', EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES . https://doi.org/10.1007/s10096-019-03723-8

Krakauer, EL, Dheda, K, Kalsdorf, B, Kuksa, L, Nadkarni, A, Nhung, NV, Selwyn, P, Shin, S, Skrahina, A & Jaramillo, E 2019, 'Palliative care and symptom relief for people affected by multidrug-resistant tuberculosis', INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, Jg. 23, Nr. 8, S. 881-890. https://doi.org/10.5588/ijtld.18.0428

Lancet Respiratory Medicine drug-resistant tuberculosis Commission group, Niemann, S & Lange, C 2019, 'The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis', Lancet Respiratory Medicine, Jg. 7, Nr. 9, S. 820-826. https://doi.org/10.1016/S2213-2600(19)30263-2

Lange, C, Aarnoutse, RE, Alffenaar, JWC, Bothamley, G, Brinkmann, F, Costa, J, Chesov, D, van Crevel, R, Dedicoat, M, Dominguez, J, Duarte, R, Grobbel, HP, Günther, G, Guglielmetti, L, Heyckendorf, J, Kay, AW, Kirakosyan, O, Kirk, O, Koczulla, RA, Kudriashov, GG, Kuksa, L, van Leth, F, Magis-Escurra, C, Mandalakas, AM, Molina-Moya, B, Peloquin, CA, Reimann, M, Rumetshofer, R, Schaaf, HS, Schön, T, Tiberi, S, Valda, J, Yablonskii, PK & Dheda, K 2019, 'Management of patients with multidrug-resistant tuberculosis', INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, Jg. 23, Nr. 6, S. 645-662. https://doi.org/10.5588/ijtld.18.0622

Lange, C, Chesov, D & Heyckendorf, J 2019, 'Clofazimine for the treatment of multidrug-resistant tuberculosis', CLINICAL MICROBIOLOGY AND INFECTION , Jg. 25, Nr. 2, S. 128-130. https://doi.org/10.1016/j.cmi.2018.11.010

Lange, C, Dheda, K, Chesov, D, Mandalakas, AM, Udwadia, Z & Horsburgh, CR 2019, 'Management of drug-resistant tuberculosis', Lancet, Jg. 394, Nr. 10202, S. 953-966. https://doi.org/10.1016/S0140-6736(19)31882-3

Lange, C, Kalsdorf, B, Maurer, FP & Heyckendorf, J 2019, 'Tuberkulose', Internist, Jg. 60, Nr. 11, S. 1155-1175. https://doi.org/10.1007/s00108-019-00685-z

Reimann, M, Schaub, D, Kalsdorf, B, Runge, C, Carballo, PS, Terhalle, E, Salzer, HJF, Lange, C & Heyckendorf, J 2019, 'Cigarette smoking and culture conversion in patients with susceptible and M/XDR-TB', INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, Jg. 23, Nr. 1, S. 93-98. https://doi.org/10.5588/ijtld.18.0354

Sane Schepisi, M, Navarra, A, Altet Gomez, MN, Dudnyk, A, Dyrhol-Riise, AM, Esteban, J, Giorgetti, PF, Gualano, G, Guglielmetti, L, Heyckendorf, J, Kaluzhenina, A, Lange, B, Lange, C, Manika, K, Miah, J, Nanovic, Z, Pontali, E, Prego, MR, Solovic, I, Tiberi, S, Palmieri, F & Girardi, E 2019, 'Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: Bnet Prevalence Survey and Case-Control Study', Open forum infectious diseases, Jg. 6, Nr. 1, S. ofy337. https://doi.org/10.1093/ofid/ofy337

 

2018

Alastruey-Izquierdo A, Cadranel J, Flick H, Godet C, Hennequin C, Hoenigl M, Kosmidis C, Lange C, Munteanu, O, Page I, Salzer HJF on behalf of CPAnet. Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives. Respiration. 2018 Jul 6:1-12. doi: 10.1159/000489474. PMID 29982245

Dalhoff K, Abele-Horn M, Andreas S, Deja M, Ewig S, Gastmeier P, Gatermann S, Gerlach H, Grabein B, Heußel CP, Höffken G, Kolditz M, Kramme E, Kühl H, Lange C, Mayer K, Nachtigall I, Panning M, Pletz M, Rath PM, Rohde G, Rosseau S, Schaaf B, Schreiter D, Schütte H, Seifert H, Spies C, Welte T; Unter Mitwirkung der folgenden Wissenschaftlichen Fachgesellschaften und Institutionen: Deutsche Gesellschaft für Chirurgie; Deutsche Gesellschaft für Innere Medizin e. V; Deutsche Gesellschaft für Internistische Intensivmedizin und Notfallmedizin; Deutsche Sepsis-Gesellschaft e. V; und Robert Koch-Institut. [Epidemiology, Diagnosis and Treatment of Adult Patients with Nosocomial Pneumonia - Update 2017 - S3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy, the German Radiological Society and the Society for Virology]. Pneumologie. 2018 Jan;72(1):15-63. doi: 10.1055/s-0043-121734. Epub 2018 Jan 16. German. PubMed PMID: 29341032

Denning DW, Page ID, Chakaya J, Jabeen K, Jude CM, Cornet M, Alastruey-Izquierdo A, Bongomin F, Bowyer P, Chakrabarti A, Gago S, Guto J, Hochhegger B, Hoenigl M, Irfan M, Irurhe N, Izumikawa K, Kirenga B, Manduku V, Moazam S, Oladele RO, Richardson MD, Tudela JLR, Rozaliyani A, Salzer HJF, Sawyer R, Simukulwa NF, Skrahina A, Sriruttan C, Setianingrum F, Wilopo BAP, Cole DC, Getahun H. Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings. Emerg Infect Dis. 2018 Aug;24(8). doi: 10.3201/eid2408.171312. PubMed PMID: 30016256; PubMed Central PMCID: PMC6056117.

Dheda K, Cox H, Esmail A, Wasserman S, Chang KC, Lange C. Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB? Respirology. 2018 Jan;23(1):36-45. doi: 10.1111/resp.13143. Epub 2017 Aug 29. Review. PMID: 28850767

Dheda K, Gumbo T, Lange C, Horsburgh Jr CR, Furin J. Pan-tuberculosis regimens: an argument against. Lancet Respir Med. 2018 Apr;6(4):240-242. doi: 10.1016/S2213-2600(18)30097-3. PMID: 29595502

Donald PR, Diacon AH, Lange C, Demers AM,  von Groote-Bidlingmaier F, Nardell EA. Droplets, dust and guinea pigs; an historical review of tuberculosis transmission research; 1878-1940. Int J Tuberc Lung Dis 2018; 22(9), 1 September: 972-982(11) doi.org/10.5588/ijtld.18.0173 PMID: 30092861

Dudnyk A, Chesov D, Lange C. Mission impossible: The EndTB Strategy. Int J Tuberc Lung Dis. 2018 Feb 1;22(2):121-122. doi: 10.5588/ijtld.17.0842. No abstract available. PMID: 29506606

Ezewudo M, Borens A, Chiner-Oms Á, Miotto P, Chindelevitch L, Starks AM, Hanna D, Liwski R, Zignol M, Gilpin C, Niemann S, Kohl TA, Warren RM, Crook D, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, McNerney R, Cirillo DM, Schito M, Rodwell TC, Posey J. Sci Rep. 2018 Oct 18;8(1):15382. doi: 10.1038/s41598-018-33731-1. PMID: 30337678

Godet C, Alastruey-Izquierdo A, Flick H, Hennequin C, Mikilps-Mikgelbs R, Munteanu O, Page I, Seidel D, Salzer HJF; CPAnet. A CPAnet consensus statement on research priorities for chronic pulmonary aspergillosis: a neglected fungal infection that requires attention. J Antimicrob Chemother. 2018 Feb 1;73(2):280-286. doi: 10.1093/jac/dkx390. PubMed PMID: 29126309.

Griffith DE, Eagle G, Thomson R, Aksamit TR, Hasegawa N, Morimoto K, Addrizzo-Harris DJ, O'Donnell AE, Marras TK, Flume PA, Loebinger MR, Morgan L, Codecasa LR, Hill AT, Ruoss SJ, Yim JJ, Ringshausen FC, Field SK, Philley JV, Wallace RJ Jr, van Ingen J, Coulter C, Nezamis J, Winthrop KL; CONVERT Study Group. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT): A Prospective, Open-Label, Randomized Study. Am J Respir Crit Care Med. 2018 Sep 14. doi: 10.1164/rccm.201807-1318OC. PMID: 30216086

Gröschel MI, Walker TM, van der Werf TS, Lange C, Niemann S, Merker M. PLoS Pathog. 2018 Oct 18;14(10):e1007297. doi: 10.1371/journal.ppat.1007297. PMID: 30335850

Guglielmetti L, Tiberi S, Burman M, Kunst H, Wejse C, TogonidzeT, Bothamley G, Lange C for the TBNET* (* additional collaborators of the TBNET: Hafizi H, Kirakosyan O, Rumetshofer R, Skrahina A, Muylle I, Zutic H, Markova R, Jankovic M, Gyorfy Z, Georgios G, Bengård Andersen A, Ravn P, Kolekar S, Danilovits M, Vasankari T, Fréchet-Jachym M,  Kiria N, Avaliani Z, Wetzstein N, Korkut Avsar K, Dimopoulos G, Horvath I, Kristjánsson M, McLaughlin AM, Chiappini E, Confalonieri M, Del Bravo, P Gualano G, Motta I, Pontali E, Tunesi  S, Kurhasani X, Kuksa L, Jacunskiene L, Wirtz Gil G, Nanovikj Z, Dumitru Chesov D, Bojovic  O , de Lange W, Magis-Escurra C, van Ingen J, Jensenius M, Kruczak K, Duarte R, Mihaescu T, Ibraim E, Kaluzhenina A, Volchenkov G, Pesut D, Ivan Solovic I, García-García JM, Luque-Márquez RM, Sánchez-Montalvá A, de Souza Galvao ML, Norrby M, Schoch O, Dudnyk A, Belton M, Martin Dedicoat M). QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: A Tuberculosis Network European Trialsgroup (TBnet) study. Eur Respir J. 2018 Jun 7. pii: 1800537. doi: 10.1183/13993003.00537-2018. PMID: 29880656

Günther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Polcová V, Popa C, Rudolf Rumetshofer, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, Lange C. Clinical management of multidrug-resistant tuberculosis in 16 European countries. Am J Respir Crit Care Med. 2018 Mar 6. doi: 10.1164/rccm.201710-2141OC. PMID: 29509468

Hargreaves S, Nellums LB, Ravensbergen SJ, Friedland JS, Stienstra Y, on behalf of the ESCMIT Working Group On Vaccination In Migrants (Beeching N, Castelli F, Carballo M, Norredam M, Leblebicioglu H, Erdem H, Carballo M, Lange C, Goletti D, Wejse C, Ozaras R, Lopez-Velez R, Tsakris A, Petersen E, Civljak R, Schlagenhauf P, Vignier N.). Divergent approaches in the vaccination of recently arrived migrants to Europe: a survey of national experts from 32 countries, 2017. Euro Surveill. 2018 Oct;23(41). doi: 10.2807/1560-7917.ES.2018.23.41.1700772. PMID: 30326996.

Heyckendorf J, Andres S, Köser CU, Olaru ID, Schön T, Sturegård E, Beckert P, Schleusener V, Kohl TA, Hillemann D, Moradigaravand D, Parkhill J, Peacock SJ, Niemann S, Lange C, Merker M. What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis. Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01550-17. doi: 10.1128/AAC.01550-17. Print 2018 Feb. PMID: 29133554

Heyckendorf  J, van Leth F, Avsar K, Glattki G, Günther G, Kalsdorf B, Müller M, Olaru ID, Rolling T, Salzer HJF, Schuhmann M, Terhalle E, Lange C. Treatment responses in multidrug-resistant tuberculosis in Germany. Int J Tuberc Lung Dis. 2018 Apr 1;22(4):399-406. doi: 10.5588/ijtld.17.0741. PMID: 29562987 (IF 2.4)

Heyckendorf J, van Leth F, Kalsdorf B, Olaru ID, Günther G, Salzer HJF, Terhalle E, Rolling TE, Glattki G, Müller M, Schuhmann M, Avsar K, Lange C. Relapse-free cure from multidrug-resistant tuberculosis in Germany. Eur Respir J. 2018 Feb 21;51(2). pii: 1702122. doi: 10.1183/13993003.02122-2017. Print 2018 Feb. No abstract available. PMID: 29467205

Jafari C, Olaru ID, Daduna F, Ernst M, Heyckendorf J, Lange C, Kalsdorf B. Rapid diagnosis of pulmonary tuberculosis by combined molecular and immunological methods. Eur Respir J. 2018 Mar 29. pii: 1702189. doi: 10.1183/13993003.02189-2017. PubMed PMID: 29599184.

Jenks JD, Salzer HJ, Prattes J, Krause R, Buchheidt D, Hoenigl M. Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy. Drug Des Devel Ther. 2018 Apr 30;12:1033-1044. doi: 10.2147/DDDT.S145545. eCollection 2018. Review. PubMed PMID: 29750016


Köser CU, Heyckendorf J, Andres S, Olaru ID, Schön T, Sturegård E, Beckert P, Schleusener V, Kohl TA, Hillemann D, Moradigaravand D, Parkhill J, Peacock SJ, Niemann S, Lange C, Merker M. 2018. Reply to Dookie et al., “Whole-genome sequencing to guide the selection of treatment for drugresistant tuberculosis.” Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00616-18. doi: 10.1128/AAC.00616-18. Print 2018 Aug. PMID: 30054377

Lange C, Chesov D, Furin J, Udwadia Z, Dheda K. Revising the definition for extensively drug-resistant tuberculosis (XDR-TB). The Lancet Respir Med. 2018 Published online November 9, 2018 http://dx.doi.org/10.1016/S2213-2600(18)30428-4  PMID: 30420247

Lange C, Alghamdi WA, Al-Shaer MH, Brighenti S, Diacon AH, DiNardo AR, Grobbel HP, Gröschel MI, von Groote-Bidlingmaier F, Hauptmann M, Heyckendorf J, Köhler N, Kohl TA, Merker M, Niemann S, Peloquin CA, Reimann M, Schaible UE, Schaub D, Schleusener V, Thye T, Schön T. Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis. J Intern Med. 2018 May 28. doi: 10.1111/joim.12780. [Epub ahead of print] Review. PMID: 29806961

Lange C, Chesov D, Heyckendorf J, Leung CC, Udwadia Z, Dheda D. Drug-resistant tuberculosis: an update on disease burden, diagnosis, and treatment. Respirology. 2018 Apr 11. doi: 10.1111/resp.13304. PMID: 29641838

Lange C, van Leth F, Mitnick CD, Dheda K, Günther G. Time to revise the WHO recommended definitions of MDR-TB treatment outcomes. Lancet Respir Med. 2018 Apr;6(4):246-248. doi: 10.1016/S2213-2600(18)30104-8. PMID: 29595505

Lange C, Chesov D, Heyckendorf J. Clofazimine for the treatment of multidrug-resistant tuberculosis. Clin Microbiol Infect. 2018 Nov 22. pii: S1198-743X(18)30737-7. doi: 10.1016/j.cmi.2018.11.010. PMID: 30472423

Olaru ID, Van Den Broucke S, Rosser AJ, Salzer HJF, Woltmann G, Bottieau E, Lange C. Pulmonary Diseases in Refugees and Migrants in Europe. Respiration. 2018 Feb 7. doi: 10.1159/000486451. [Epub ahead of print] PMID: 29414830

Radloff J, Heyckendorf J, van der Merwe L, Sanchez-Carballo P, Reiling N, Richter E, Lange C, Kalsdorf B. Mycobacterium growth inhibition assay of human alveolar macrophages as a correlate of immune protection following M. bovis BCG-vaccination. Front Immunol. 2018 Jul 24;9:1708. doi: 10.3389/fimmu.2018.01708. eCollection 2018. PMID: 30087678

Ravensbergen SJ, Nellums LB, Hargreaves S, Stienstra Y, Friedland JS; ESGITM Working Group on Vaccination in Migrants (Beeching N, Castelli F, Carballo M, Norredam M, Leblebicioglu H, Erdem H, Carballo M, Lange C, Goletti D, Wejse C, Ozaras R, Lopez-Velez R, Tsakris A, Petersen E, Civljak R, Schlagenhauf P, Vignier N.); with the support of the Executive Committee and Membership of ESGITM. National approaches to the vaccination of recently arrived migrants in Europe: A  comparative policy analysis across 32 European countries. Travel Med Infect Dis. 2018 Oct 15. pii: S1477-8939(18)30366-1. doi: 10.1016/j.tmaid.2018.10.011. PMID: 30336255  

Salzer HJF, Burchard G, Cornely OA, Lange C, Rolling T, Schmiedel S, Libman M, Capone D, Le T, Dalcolmo MP, Heyckendorf J. Diagnosis and Management of Systemic Endemic Mycoses Causing Pulmonary Disease. Respiration. 2018 Jun 28:1-19. doi: 10.1159/000489501. [Epub ahead of print] PMID: 29953992

Salzer HJF, Prattes J, Flick H, Reimann M, Heyckendorf J, Kalsdorf B, Obersteiner S, Gaede KI, Herzmann C, Johnson GL, Lange C, Hoenigl M. Front Microbiol. 2018 Oct 2;9:2223. doi: 10.3389/fmicb.2018.02223. eCollection 2018. PMID: 30333797

Salzer HJF, Schäfer G, Hoenigl M, Günther G,  Hoffmann C, Kalsdorf B,  Alanio A, Lange C. Clinical, diagnostic and treatment disparities between HIV-infected and non-HIV-infected immunocompromised patients with Pneumocystis jirovecii pneumonia. Respiration 2018 Apr 10. doi: 10.1159/000487713. PMID 29635251

Salzer HJF, Stoney RJ, Angelo KM, Rolling T, P. Grobusch MP, Libman M, López-Vélez R, Duvignaud A, Ásgeirsson H, Crespillo-Andújar C, Schwartz E, Gautret P, Bottieau E, Jordan S, Lange C, Hamer DH, for the GeoSentinel Surveillance Network. Epidemiological aspects of travel-related systemic endemic mycoses: a GeoSentinel analysis, 1997–2017. J Travel Med. 2018 Aug 1;25(1). doi: 10.1093/jtm/tay055. PMID: 30085265

Salzer HJH, Kuempers C, Pasternack H,  Heyckendorf J,  Bialek R,  Palade E,  Hundack L, Kalsdorf B,  Lange C. An unexpected endobronchial mass appearing during bronchoscopy. CHEST 2018; 154(1):e13-e21 PMID 30044749

Shah S, Lange C, Lonnroth K, Reflections on the “TB and Migration State-of-the-Art Series” and the Way Forward. Int J Tuberc Lung Dis. 2018 Aug 1;22(8):829. doi: 10.5588/ijtld.18.0415. PMID 29991386

The Collaborative Group for the Analysis of Individual Patient Data in MDR-TB treatment. Members of the Group (in alphabetic order): Ahmad A, Ahuja SD, Akkerman OW, Alffenaar JWV, Anderson LF, Baghaei Shiva P, Bang D, Barry CE, Barry PM, Bastos ML, Behera DB, Benedetti A, Bisson GP, Boeree M, Bonnet M, Brode S, Brust JCM, Cai Y, Carlessso GF, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Chen R, Cirule A, D’Ambrosio L, de Vries G, Dheda K, Esmail A, Falzon D, Flood J, Fox G, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Frechet-Jachym M, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Liga Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Leimane V, Leung CC, Leung ECC, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Menzies D, Migliori GB, Milanov V, Miller AC, Mitnick C, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O’Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu T, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilbrun SC, Walsh K, Westenhouse J, Yew WW, Yim JJ, Zetola NM, Zignol M. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis– an individual patient data meta-analysis of 12,030 patients from 25 countries. The Lancet. 2018 Sep 8;392(10150):821-834. doi: 10.1016/S0140-6736(18)31644-1. PMID: 30215381

Ullmann A, Aguado JM, Arikan S, Denning D, Groll A; Lagrou K, Lass-Florl C, Lewis R, Muñoz P, Verweij P, Warris A, Akova M,  Arendrup MC,  Barnes R,  Blot S,  Bouza E, Brüggemann RJM, Buchheidt D,  Cadranel J,  Chakrabarti A, Cuenca-EstrellaM,  Dimopoulos G, Gangneux JP,  Garbino J,  Heinz W, Herbrecht R, Kibbler C, Klimko N,  Kullberg BJ,  Lange C,  Lehrnbecher T,  Loeffler J, Lortholary O,  Maertens J, Cornely O.Diagnosis and Management of Aspergillus Diseases: Executive Summary of the 2017 ESCMID-ECMM-ERS Guideline. Clin Microbiol Infect. 2018 Mar 12. pii: S1198-743X(18)30051-X. doi: 10.1016/j.cmi.2018.01.002. [Epub ahead of print]. PMID: 29544767

van Ingen J, Aksamit T Andréjak C, Böttger E, Cambau E, Daley C,  Griffith, DE, Guglielmetti L,  Holland S, Huitt G,  Koh WJ,  Lange C,  Leitman P,  Marras T,  Morimoto K, Olivier K, Santin M, Stout J, Rachel T,  Tortoli E, Wallace R,  Winthrop K,  Wagner D. Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease – an NTM-NET consensus statement. Eur Respir J. 2018 Mar 22;51(3). pii: 1800170. doi: 10.1183/13993003.00170-2018. Print 2018 Mar. No abstract available. PMID: 29567726

Walker TM, Merker M, Knoblauch AM, Helbling P, Schoch OD van der Werf MJ, Kranzer, K, Fiebig L, Kröger S, Haas W, Hoffmann H, Indra A, Egli A, Cirillo DM, Robert J, Rogers TR, Groenheit R, Mengshoel AT, Mathys V, Haanperä M, van Soolingen D, Niemann S, Böttger E, Keller PM and the MDR-TB Cluster Consortium (Avsar K, Bauer C, Bernasconi E, Borroni E, Brusin S, Dévis MC, Crook DW, Dedicoat M, Fitzgibbon M, Gagneux S, Geiger F, Guthmann JP, Hendrickx D, Hoffmann-Thiel S, van Ingen J, Jackson S, Jaton K, Lange C, Mazza Stalder J, O'Donnell J, Opota P, Peto TEA, Preiswerk B, Roycroft E, Sato M, Schacher R, Schulthess B, E. Smith EG, Soini H, Sougakoff W, Tagliani E, Utpatel C, Veziris N, Wagner-Wiening C, Witschi M). A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study. Lancet Infect Dis. 2018 Jan 8. pii: S1473-3099(18)30004-5. doi: 10.1016/S1473-3099(18)30004-5. PMID: 29326013  (IF 25.1)

Zallet J, Olaru ID, Witt AK, Vock P, Kalsdorf B, Andres S, Hillemann D, Kranzer K. Evaluation of OMNIgene(®) SPUTUM reagent for mycobacterial culture. Int J Tuberc Lung Dis. 2018 Aug 1;22(8):945-949. doi: 10.5588/ijtld.17.0020. PMID: 29991406.

 

2017

Salzer, HJF, Lange, C & Hönigl, M 2017, 'Aspergillus-Nachweis im Atemwegsmaterial: Ignorieren oder behandeln?' Internist, Bd 58, Nr. 11, S. 1150-1162. DOI: 10.1007/s00108-017-0334-9

Miotto, P, Tessema, B, Tagliani, E, Chindelevitch, L, Starks, AM, Emerson, C, Hanna, D, Kim, PS, Liwski, R, Zignol, M, Gilpin, C, Niemann, S, Denkinger, CM, Fleming, J, Warren, RM, Crook, D, Posey, J, Gagneux, S, Hoffner, S, Rodrigues, C, Comas, I, Engelthaler, DM, Murray, M, Alland, D, Rigouts, L, Lange, C, Dheda, K, Hasan, R, Ranganathan, UDK, McNerney, R, Ezewudo, M, Cirillo, DM, Schito, M, Köser, CU & Rodwell, TC 2017, 'A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis' The European respiratory journal, Bd 50, Nr. 6. DOI: 10.1183/13993003.01354-2017

Salzer, HJF & Cornely, OA 2017, 'Awareness of predictors of mortality may help improve outcome in chronic pulmonary aspergillosis' The European respiratory journal, Bd 49, Nr. 2. DOI: 10.1183/13993003.02520-2016

Olaru, ID, Heyckendorf, J, Andres, S, Kalsdorf, B & Lange, C 2017, 'Bedaquiline-based treatment regimen for multidrug-resistant tuberculosis' The European respiratory journal, Bd 49, Nr. 5. DOI: 10.1183/13993003.00742-2017

Salzer, HJF, Heyckendorf, J, Kalsdorf, B, Rolling, T & Lange, C 2017, 'Characterization of patients with chronic pulmonary aspergillosis according to the new ESCMID/ERS/ECMM and IDSA guidelines' Mycoses, Bd 60, Nr. 2, S. 136-142. DOI: 10.1111/myc.12589

Dheda, K, Chang, KC, Guglielmetti, L, Furin, J, Schaaf, HS, Chesov, D, Esmail, A & Lange, C 2017, 'Clinical management of adults and children with MDR and XDR-TB' CLINICAL MICROBIOLOGY AND INFECTION , Bd 23, Nr. 3, S. 131-140. DOI: 10.1016/j.cmi.2016.10.008

Labugger, I, Heyckendorf, J, Dees, S, Häussinger, E, Herzmann, C, Kohl, TA, Richter, E, Rivera-Milla, E & Lange, C 2017, 'Detection of transrenal DNA for the diagnosis of pulmonary tuberculosis and treatment monitoring' INFECTION, Bd 45, Nr. 3, S. 269-276. DOI: 10.1007/s15010-016-0955-2

Bunjun, R, Riou, C, Soares, AP, Thawer, N, Müller, TL, Kiravu, A, Ginbot, Z, Oni, T, Goliath, R, Kalsdorf, B, von Groote-Bidlingmaier, F, Hanekom, W, Walzl, G, Wilkinson, RJ & Burgers, WA 2017, 'Effect of HIV on the frequency and number of Mycobacterium tuberculosis-specific CD4+ T cells in blood and the airways in latent tuberculosis infection' JOURNAL OF INFECTIOUS DISEASES, Bd 216, Nr. 12. DOI: 10.1093/infdis/jix529

Olaru, ID, McHugh, G, Dakshina, S, Majonga, E, Dauya, E, Bandason, T, Kranzer, K, Mujuru, H & Ferrand, RA 2017, 'False-negative HIV tests using oral fluid tests in children taking antiretroviral therapy from Harare, Zimbabwe' AIDS, Bd 20, Nr. Suppl 6, S. 21751. DOI: 10.7448/IAS.20.7.21751

Salzer, HJF, Rolling, T, Vinnemeier, CD, Tannich, E, Schmiedel, S, Addo, MM & Cramer, JP 2017, 'Helminthic infections in returning travelers and migrants with eosinophilia: Diagnostic value of medical history, eosinophil count and IgE' Travel medicine and infectious disease, Bd 20, S. 49-55. DOI: 10.1016/j.tmaid.2017.09.001

Chesov, D, Ciobanu, N, Lange, C, Heyckendorf, J & Crudu, V 2017, 'High-dose isoniazid in the shorter-course multidrug-resistant tuberculosis regimen in the Republic of Moldova' The European respiratory journal, Bd 50, Nr. 4. DOI: 10.1183/13993003.01340-2017

Allerberger, F, Cambau, E & Lange, C 2017, 'Joint efforts urgently needed at times of emerging tuberculosis drug resistance' CLINICAL MICROBIOLOGY AND INFECTION , Bd 23, Nr. 3, S. 129-130. DOI: 10.1016/j.cmi.2016.08.023

Chesov, D, Ciobanu, N, Lange, C, Schön, T, Heyckendorf, J & Crudu, V 2017, 'Lack of evidence of isoniazid efficacy for the treatment of MDR/XDR-TB in the presence of the katG 315T mutation' The European respiratory journal, Bd 50, Nr. 4. DOI: 10.1183/13993003.01752-2017

Nakiwala, D, Kellgren, L, Herzmann, C, Olaru, ID, Brown, M, Ferrand, RA, Khan, P & Kranzer, K 2017, 'Language discordance between tuberculosis patients and healthcare providers challenging universal access' The European respiratory journal, Bd 49, Nr. 4. DOI: 10.1183/13993003.00116-2017

Dudnyk, A, Butov, D, Crudu, V, Lange, C & Chesov, D 2017, 'MDR-TB in Eastern Europe in the era of the TB elimination action framework' INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, Bd 21, Nr. 1, S. 2-3. DOI: 10.5588/ijtld.16.0732

Hargreaves, S, Lönnroth, K, Nellums, LB, Olaru, ID, Nathavitharana, RR, Norredam, M & Friedland, JS 2017, 'Multidrug-resistant tuberculosis and migration to Europe' CLINICAL MICROBIOLOGY AND INFECTION , Bd 23, Nr. 3, S. 141-146. DOI: 10.1016/j.cmi.2016.09.009

Heyckendorf, J, Brede, S, Guo, X, Haberl, B & Sayk, F 2017, 'Mutter und Sohn zwischen Allmacht und Koma' Medizinische Klinik, Intensivmedizin und Notfallmedizin, Bd 112, Nr. 6, doi: 10.1007/s00063-016-0238-9., S. pp 531–534. DOI: 10.1007/s00063-016-0238-9

Kodama, C, Lange, B, Olaru, ID, Khan, P, Lipman, M, Seddon, JA, Sloan, D, Grandjean, L, Ferrand, RA & Kranzer, K 2017, 'Mycobacterium tuberculosis transmission from patients with drug-resistant compared to drug-susceptible TB: a systematic review and meta-analysis' The European respiratory journal, Bd 50, Nr. 4. DOI: 10.1183/13993003.01044-2017

Munteanu, O & Salzer, HJF 2017, 'Non-Cystic Fibrosis Bronchiectasis: from Programmatic Management to Personalized Medicine' RESPIRATION, Bd 93, Nr. 6, S. 404-405. DOI: 10.1159/000473885

Bahmer, T, Waschki, B, Schatz, F, Herzmann, C, Zabel, P, Kirsten, A-M, Rabe, KF, Watz, H & ERA-Study Group 2017, 'Physical activity, airway resistance and small airway dysfunction in severe asthma' The European respiratory journal, Bd 49, Nr. 1, S. pii 1601827. DOI: 10.1183/13993003.01827-2016

van Ingen, J, Wagner, D, Gallagher, J, Morimoto, K, Lange, C, Haworth, CS, Floto, RA, Adjemian, J, Prevots, DR, Griffith, DE & NTM-NET 2017, 'Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases' The European respiratory journal, Bd 49, Nr. 2, S. pii 1601855. DOI: 10.1183/13993003.01855-2016

Herzmann, C, Ernst, M, Lange, C, Stenger, S, Kaufmann, SHE, Reiling, N, Schaberg, T, van der Merwe, L, Maertzdorf, J & Tb or not Tb consortium 2017, 'Pulmonary immune responses to Mycobacterium tuberculosis in exposed individuals' PLOS ONE, Bd 12, Nr. 11, S. e0187882. DOI: 10.1371/journal.pone.0187882

Herzmann, C, Golakov, M, Malekzada, F, Lonnroth, K & Kranzer, K 2017, 'Radiological screening of refugees in Germany' The European respiratory journal, Bd 49, Nr. 5. DOI: 10.1183/13993003.02487-2016

van Leth, F, Günther, G, Hoffmann, H, Lange, C & European MDR-TB database collaboration 2017, 'Reply from the Authors of Limited Benefit of the New Shorter MDR-TB Regimen in Europe' American journal of respiratory and critical care medicine, Bd 196, Nr. 11, S. 1489-1490. DOI: 10.1164/rccm.201705-0995LE

Schaberg, T, Bauer, T, Brinkmann, F, Diel, R, Feiterna-Sperling, C, Haas, W, Hartmann, P, Hauer, B, Heyckendorf, J, Lange, C, Nienhaus, A, Otto-Knapp, R, Priwitzer, M, Richter, E, Rumetshofer, R, Schenkel, K, Schoch, OD, Schönfeld, N & Stahlmann, R 2017, 'S2k-Leitlinie: Tuberkulose im Erwachsenenalter' Pneumologie (Stuttgart, Germany), Bd 71, Nr. 6, S. 325-397. DOI: 10.1055/s-0043-105954

Dheda, K, Gumbo, T, Maartens, G, Dooley, KE, McNerney, R, Murray, M, Furin, J, Nardell, EA, London, L, Lessem, E, Theron, G, van Helden, PD, Niemann, S, Merker, M, Dowdy, D, Van Rie, A, Siu, GKH, Pasipanodya, JG, Rodrigues, C, Clark, TG, Sirgel, FA, Esmail, A, Lin, H-H, Atre, SR, Schaaf, HS, Chang, K-C, Lange, C, Nahid, P, Udwadia, ZF, Horsburgh, CR, Churchyard, GJ, Menzies, D, Hesseling, AC, Nuermberger, E, McIlleron, H, Fennelly, KP, Goemaere, E, Jaramillo, E, Low, M, Jara, CM, Padayatchi, N & Warren, RM 2017, 'The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis' Lancet Respiratory Medicine. DOI: 10.1016/S2213-2600(17)30079-6

Silkoff, PE, Flavin, S, Gordon, R, Loza, MJ, Sterk, PJ, Lutter, R, Diamant, Z, Turner, RB, Lipworth, BJ, Proud, D, Singh, D, Eich, A, Backer, V, Gern, JE, Herzmann, C, Halperin, SA, Mensinga, TT, Del Vecchio, AM, Branigan, P, San Mateo, L, Baribaud, F, Barnathan, ES & Johnston, SL 2017, 'TLR3 Blockade in Rhinovirus-Induced Experimental Asthma Exacerbations: A Randomized Controlled Study' The Journal of allergy and clinical immunology. DOI: 10.1016/j.jaci.2017.06.027

Magis-Escurra, C, Günther, G, Lange, C, Alexandru, S, Altet, N, Avsar, K, Bang, D, Barbuta, R, Bothamley, GH, Ciobanu, A, Crudu, V, Davilovits, M, Dedicoat, M, Duarte, R, Gualano, G, Kunst, H, de Lange, WCM, Leimane, V, McLaughlin, A-M, Muylle, I, Polcová, V, Popa, C, Rumetshofer, R, Skrahina, A, Solodovnikova, V, Spinu, V, Tiberi, S, Viiklepp, P, van Leth, F & for TBnet 2017, 'Treatment outcomes of MDR-TB and HIV co-infection in Europe' The European respiratory journal, Bd 49, Nr. 6. DOI: 10.1183/13993003.02363-2016

Lönnroth, K, Mor, Z, Erkens, C, Bruchfeld, J, Nathavitharana, RR, van der Werf, MJ & Lange, C 2017, 'Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points' INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, Bd 21, Nr. 6, S. 624-637. DOI: 10.5588/ijtld.16.0845

Dedicoat, MJ, Günther, G, Crudu, V, Duarte, R, Gualano, G, Magis-Escurra, C, Rumetshofer, R, Skrahina, A, Spinu, V, Tiberi, S, Viiklepp, P, van Leth, F, Lange, C & TBNET 2017, 'Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure' American journal of respiratory and critical care medicine, Bd 196, Nr. 9, S. 1222-1224. DOI: 10.1164/rccm.201612-2585LE

Heyckendorf, J, Andres, S, Köser, CU, Olaru, ID, Schön, T, Sturegård, E, Beckert, P, Schleusener, V, Kohl, TA, Hillemann, D, Moradigaravand, D, Parkhill, J, Peacock, SJ, Niemann, S, Lange, C & Merker, M 2017, 'What is resistance?: Impact of phenotypic versus molecular drug resistance testing on multi- and extensively drug-resistant tuberculosis therapy' ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. DOI: 10.1128/AAC.01550-17